Evidence map›Paper›PMID 38408053›Full record

ArticlePloS one2024

Epidemiology and infection control of vancomycin-resistant enterococci at a German university hospital: A three-year retrospective cohort study.

Adrian Jochim-Vukosavic, Frank Schwab, Leonard Knegendorf, Dirk Schlüter, Franz-Christoph Bange, Ella Ebadi, Claas Baier

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Genomic epidemiology ofJournal of clinical microbiology · 2026
    Observational
  3. Review
  4. Article
  5. Article
  6. Spread of the novel vancomycin-resistantEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Observational
  7. Deciphering vancomycin resistance inFrontiers in microbiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Adrian Jochim-VukosavicHannover Medical School, Institute for Medical Microbiology and Hospital Epidemiology, Hannover, Germany.
Frank SchwabInstitute of Hygiene and Environmental Medicine, Charité-University Medicine, Berlin, Germany.
Leonard KnegendorfHannover Medical School, Institute for Medical Microbiology and Hospital Epidemiology, Hannover, Germany.ORCID 0000-0001-8469-1248
Dirk SchlüterHannover Medical School, Institute for Medical Microbiology and Hospital Epidemiology, Hannover, Germany.
Franz-Christoph BangeHannover Medical School, Institute for Medical Microbiology and Hospital Epidemiology, Hannover, Germany.
Ella EbadiHannover Medical School, Institute for Medical Microbiology and Hospital Epidemiology, Hannover, Germany.
Claas BaierHannover Medical School, Institute for Medical Microbiology and Hospital Epidemiology, Hannover, Germany.ORCID 0000-0003-3895-5446
Medizinische Hochschule Hannover · DECharité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vancomycin-resistant enterococci (VRE) occur in hospitalized patients, causing both infection and colonization. In recent years, there has been an increase in VRE in German and other hospitals, raising the question of how to control this epidemic best. To better understand the specific epidemiology and to guide infection control, we conducted a retrospective cohort study analyzing all patients with VRE at Hannover Medical School, a tertiary university clinic in Germany that specializes in solid organ transplantation. Epidemiologic and clinical characteristics of patients with VRE from 2015-2017 were collected. Basic epidemiologic parameters, including VRE incidence and incidence density, were calculated. Independent risk factors for nosocomial VRE infection compared to colonization were assessed using a logistic regression model. There were 1,492 VRE cases corresponding to 822 individual patients. The incidence was 0.8 VRE cases per 100 cases. A total of 536 (35.9%) of the 1,492 VRE cases were acquired nosocomially. Of the 1,492 cases, 912 cases had VRE-positive samples (894 Enterococcus (E.) faecium and 18 E. faecalis) in our hospital laboratory and the remaining cases were known VRE carriers. The vanB-phenotype was observed in 369 of the 894 (41.3%) E. faecium isolates and in 6 of the 18 (33.3%) E. faecalis isolates. There was an increase over time in the vanB-phenotype proportion in E. faecium (2015: 63 of 171, 36.8%, 2016: 115 of 322, 35.7% and 2017: 191 of 401, 47.6%). A total of 107 cases had a VRE infection (7.2% of all VRE cases) according to the criteria of the German National Reference Center for Surveillance of Nosocomial Infections. The remaining cases were only colonized. Among other factors, leukocytopenia (<1,000/μL), the use of a central venous catheter and the visceral surgery medical specialty were independently associated with nosocomial VRE infection. VRE imposed a relevant and increasing infection control burden at our hospital. Nosocomial VRE infection was predominantly found in certain medical specialties, such as hematology and oncology and visceral surgery. Infection control efforts should focus on these highly affected patient groups/specialties.

Indexed as

Cross InfectionEnterococcus faeciumGram-Positive Bacterial InfectionsVancomycin-Resistant EnterococciAnti-Bacterial AgentsHospitals, UniversityHumansInfection ControlRetrospective StudiesAnti-Bacterial Agents

Identifiers

PMID38408053
PMCPMC10896503
OpenAlexW4392167364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.